跳至主要内容
临床试验/NCT05399615
NCT05399615撤回不适用

Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study

Scentech Medical Technologies Ltd2 个研究点 分布在 1 个国家开始时间: 2022年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Discovery of exhaled breath biomarkers

研究概览

简要总结

Detection of bacterial and viral pathogens infection among hospitalized patients using breath analysis - feasibility study.

详细描述

A diagnostic prospective single-site study, with no anticipated risks or constraints.

Primary objective: To identify a set of breath Volatile Organic Compound biomarkers that enable the detection of pathogens infection and inflammatory response to pathogens infection among hospitalized patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 80 years at the time of consent
  • Capable of understanding written and/or spoken language
  • Able to provide informed consent
  • Negative results for SARS-CoV-2
  • Diagnosed with suspected respiratory infection

排除标准

  • Under guardianship or deprived of liberty
  • Pregnant or lactating woman
  • Not able to breathe through mask for 8 minutes
  • Intubated patients
  • Patients in critical condition
  • Diagnosed with hospital-acquired infection
  • Medical history of malignancies

结局指标

主要结局

Discovery of exhaled breath biomarkers

时间窗: Through the study completion, up to 3 months.

To evaluate the sensitivity, specificity, positive and negative predictive value of metabolomic biomarkers in exhaled breath samples as compared with pathogens biomarkers found in participants' blood and sputum samples.

次要结局

  • The association of exhaled biomarkers with inflammatory known biomarkers.(Through the study completion, up to 3 months.)

研究者

发起方
Scentech Medical Technologies Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验